Latest News
- Acne Resource Center
Friday, September 28, 2018
Bellus Medical Now Part of Crown Laboratories
Crown Laboratories, Inc. and Hildred Capital Partners, LLC have acquired Bellus Medical. Bellus’s non-invasive offerings include the SkinPen, a medical grade microneedling device used exclusi…
Read the full storyMonday, July 23, 2018
TruDerm Adds Second Dermatology Center
TruDerm, a growing medical and cosmetic dermatology practice offering skin care seven days a week is opening its second DFW facility in Plano, TX at Legacy West. Staffed by Board Certified De…
Read the full story
Friday, July 20, 2018
BioPharmX: FDA Grants CARC Waiver; Post-Hoc Analysis for BPX-01 Complete
The FDA has waived its requirement for a dermal carcinogenicity study for BPX-01 from BioPharmX Corporation, eliminating several years of non-clinical research normally required for FDA review. BPX…
Read the full storyWednesday, July 11, 2018
Fourth Generation Retinoid Shows Promise in Acne Trials
New research reveals that trifarotene, a fourth-generation retinoid with potent and selective activity against only one particular retinoic acid receptor, may have an improved efficacy and safety prof…
Read the full story
Tuesday, June 19, 2018
New Patient-Centered Panel Helps BioPharmX Define its Role in the Future of Dermatology
BioPharmX Corporation has formed a Special Advisory Council of thought leaders from various disciplines to help the company embrace patient centricity in its products, pricing, and market access consi…
Read the full storyMonday, June 04, 2018
Spironolactone May Be an Alternative to Antibiotics in Female Acne
The diuretic drug spironolactone may be just as effective as antibiotics for the treatment of women’s acne, report researchers from the Perelman School of Medicine at the University of Pennsylva…
Read the full story
Monday, April 30, 2018
New Phase 4 Data: Epiduo Forte Gel Decreased Acne Lesions, Reduced Risk of Scars
Results from OSCAR, a Phase 4, multicenter, randomized, investigator-blinded, vehicle-controlled, intra-individual comparison study (right/left half-face), revealed that Epiduo Forte (adapalene a…
Read the full storyMonday, March 05, 2018
Dermira: Two Phase 3 Trials Evaluating Olumacostat Glasaretil in Patients with Acne Vulgaris Did Not Meet Co-Primary Endpoints
Dermira, Inc.'s investigational treatment olumacostat glasaretil (formerly DRM01) did not meet the co-primary endpoints in its two Phase 3 pivotal trials (CLAREOS-1 and CLAREOS-2) in patients ages…
Read the full storyThursday, February 22, 2018
Vit D Levels Elevated in Acne
Levels of vitamin D are higher in acne patients, compared to age/sex matched controls. Researchers found a significant inverse relation between level of 25 hydroxy vitamin D and severity of acne vulga…
Read the full storyWednesday, February 07, 2018
Research Finds Acne Linked with Increased Risk of Depression
In an analysis of one of the largest electronic medical records databases in the world, researchers found that patients with acne had a significantly increased risk of developing major depression, but…
Read the full story
